JP2011526616A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011526616A5 JP2011526616A5 JP2011515631A JP2011515631A JP2011526616A5 JP 2011526616 A5 JP2011526616 A5 JP 2011526616A5 JP 2011515631 A JP2011515631 A JP 2011515631A JP 2011515631 A JP2011515631 A JP 2011515631A JP 2011526616 A5 JP2011526616 A5 JP 2011526616A5
- Authority
- JP
- Japan
- Prior art keywords
- thiazolidine
- dione
- methylidene
- phenyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 24
- 239000008194 pharmaceutical composition Substances 0.000 claims description 10
- 206010028980 Neoplasm Diseases 0.000 claims description 5
- 201000011510 cancer Diseases 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 101100297652 Coturnix japonica PIM3 gene Proteins 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 101100297651 Mus musculus Pim2 gene Proteins 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 101001001642 Xenopus laevis Serine/threonine-protein kinase pim-3 Proteins 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- -1 nitro, cyano, hydroxy, amino, mercapto, formyl Chemical group 0.000 description 207
- 125000000217 alkyl group Chemical group 0.000 description 29
- 229910052736 halogen Inorganic materials 0.000 description 21
- 150000002367 halogens Chemical class 0.000 description 21
- 125000000623 heterocyclic group Chemical group 0.000 description 18
- 125000004452 carbocyclyl group Chemical group 0.000 description 17
- 125000003118 aryl group Chemical group 0.000 description 16
- 229910052739 hydrogen Inorganic materials 0.000 description 15
- 239000001257 hydrogen Substances 0.000 description 15
- 150000002431 hydrogen Chemical class 0.000 description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 13
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 description 11
- 125000003545 alkoxy group Chemical group 0.000 description 10
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 8
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 description 7
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 description 7
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 7
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 7
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 7
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 7
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 7
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 description 5
- 125000001589 carboacyl group Chemical group 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 4
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
- 125000005153 alkyl sulfamoyl group Chemical group 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- HVMFXMXOKHYZGH-QPEQYQDCSA-N (5z)-5-[[2-(3-amino-4-methylpiperidin-1-yl)-3-chlorophenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1C(N)C(C)CCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 HVMFXMXOKHYZGH-QPEQYQDCSA-N 0.000 description 1
- JXSNYJNREMWSDJ-DKBJHAQFSA-N (5z)-5-[[2-[(3r)-3-(aminomethyl)pyrrolidin-1-yl]-3-chlorophenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](CN)CCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 JXSNYJNREMWSDJ-DKBJHAQFSA-N 0.000 description 1
- MDFJCKNNJJLLKS-HDOAHBKWSA-N (5z)-5-[[2-[(3r)-3-[[4-(aminomethyl)phenyl]methylamino]piperidin-1-yl]-3-chlorophenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1=CC(CN)=CC=C1CN[C@H]1CN(C=2C(=CC=CC=2Cl)\C=C/2C(NC(=O)S\2)=O)CCC1 MDFJCKNNJJLLKS-HDOAHBKWSA-N 0.000 description 1
- DXTSXAULWQSFNT-NUBYWOLOSA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-(2,2,2-trifluoroethoxy)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](N)CCCN1C1=C(OCC(F)(F)F)C=CC=C1\C=C/1C(=O)NC(=O)S\1 DXTSXAULWQSFNT-NUBYWOLOSA-N 0.000 description 1
- NQPRGWXCFHMQPV-NWFCWYBLSA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-(2-methoxyethoxy)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C([C@H](N)CCC1)N1C=1C(OCCOC)=CC=CC=1\C=C1/SC(=O)NC1=O NQPRGWXCFHMQPV-NWFCWYBLSA-N 0.000 description 1
- FBEUTZRQCSCWQM-SLVCOGOPSA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-(2-methylpropoxy)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C([C@H](N)CCC1)N1C=1C(OCC(C)C)=CC=CC=1\C=C1/SC(=O)NC1=O FBEUTZRQCSCWQM-SLVCOGOPSA-N 0.000 description 1
- PYWZTKODXYPZLR-VPMLRQHESA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-bromophenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](N)CCCN1C1=C(Br)C=CC=C1\C=C/1C(=O)NC(=O)S\1 PYWZTKODXYPZLR-VPMLRQHESA-N 0.000 description 1
- ZLDXTUTZYPVCKG-VPMLRQHESA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-chlorophenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](N)CCCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 ZLDXTUTZYPVCKG-VPMLRQHESA-N 0.000 description 1
- ILDFZJPHSLRCEK-YDRQLGOLSA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-cyclobutyloxyphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](N)CCCN1C(C(=CC=C1)\C=C/2C(NC(=O)S\2)=O)=C1OC1CCC1 ILDFZJPHSLRCEK-YDRQLGOLSA-N 0.000 description 1
- YCYIBOYEPOLGSN-PWDRBQJJSA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-cyclohexyloxyphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](N)CCCN1C(C(=CC=C1)\C=C/2C(NC(=O)S\2)=O)=C1OC1CCCCC1 YCYIBOYEPOLGSN-PWDRBQJJSA-N 0.000 description 1
- BVHIMRZDAQRPHV-RQNDZEIBSA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-cyclopentyloxyphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](N)CCCN1C(C(=CC=C1)\C=C/2C(NC(=O)S\2)=O)=C1OC1CCCC1 BVHIMRZDAQRPHV-RQNDZEIBSA-N 0.000 description 1
- YPGUAMCIYVJFOJ-OJLMPMFISA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-ethoxyphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C([C@H](N)CCC1)N1C=1C(OCC)=CC=CC=1\C=C1/SC(=O)NC1=O YPGUAMCIYVJFOJ-OJLMPMFISA-N 0.000 description 1
- GJSKIXCETHIGQQ-JYVXZMADSA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-methoxyphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C([C@H](N)CCC1)N1C=1C(OC)=CC=CC=1\C=C1/SC(=O)NC1=O GJSKIXCETHIGQQ-JYVXZMADSA-N 0.000 description 1
- MCUJKPPARUPFJM-UWCCDQBKSA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-phenylphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](N)CCCN1C(C(=CC=C1)C=2C=CC=CC=2)=C1\C=C/1C(=O)NC(=O)S\1 MCUJKPPARUPFJM-UWCCDQBKSA-N 0.000 description 1
- ULMRMVZQMKZWKJ-MLJKTZRHSA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-propan-2-yloxyphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C([C@H](N)CCC1)N1C=1C(OC(C)C)=CC=CC=1\C=C1/SC(=O)NC1=O ULMRMVZQMKZWKJ-MLJKTZRHSA-N 0.000 description 1
- WLJWSUVXFQUAHY-JYVXZMADSA-N (5z)-5-[[2-[(3r)-3-aminopiperidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](N)CCCN1C1=CC=CC=C1\C=C/1C(=O)NC(=O)S\1 WLJWSUVXFQUAHY-JYVXZMADSA-N 0.000 description 1
- NJYIOPRYGAGQCB-NJQKBMNKSA-N (5z)-5-[[2-[(3r)-3-aminopyrrolidin-1-yl]-3-chlorophenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](N)CCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 NJYIOPRYGAGQCB-NJQKBMNKSA-N 0.000 description 1
- DGGXDXTZQQQTKL-OYHMZJHOSA-N (5z)-5-[[2-[(3r,4r)-3-amino-4-hydroxypiperidin-1-yl]-3-chlorophenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1C[C@@H](O)[C@H](N)CN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 DGGXDXTZQQQTKL-OYHMZJHOSA-N 0.000 description 1
- JXSNYJNREMWSDJ-TXEUWIOXSA-N (5z)-5-[[2-[(3s)-3-(aminomethyl)pyrrolidin-1-yl]-3-chlorophenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](CN)CCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 JXSNYJNREMWSDJ-TXEUWIOXSA-N 0.000 description 1
- GSCZVAZFVSJNDT-OGGBREFQSA-N (5z)-5-[[2-[(3s)-3-aminopyrrolidin-1-yl]-3-(2,2,2-trifluoroethoxy)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N)CCN1C1=C(OCC(F)(F)F)C=CC=C1\C=C/1C(=O)NC(=O)S\1 GSCZVAZFVSJNDT-OGGBREFQSA-N 0.000 description 1
- LPJHRWXRKNBEMC-CJAAZZPWSA-N (5z)-5-[[2-[(3s)-3-aminopyrrolidin-1-yl]-3-(2-methoxyethoxy)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C([C@@H](N)CC1)N1C=1C(OCCOC)=CC=CC=1\C=C1/SC(=O)NC1=O LPJHRWXRKNBEMC-CJAAZZPWSA-N 0.000 description 1
- LRGBUXCKVLHMRX-ISAHRAOESA-N (5z)-5-[[2-[(3s)-3-aminopyrrolidin-1-yl]-3-bromophenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N)CCN1C1=C(Br)C=CC=C1\C=C/1C(=O)NC(=O)S\1 LRGBUXCKVLHMRX-ISAHRAOESA-N 0.000 description 1
- FCICTBXGGPCMIE-SYUPGTOSSA-N (5z)-5-[[2-[(3s)-3-aminopyrrolidin-1-yl]-3-chloro-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N)CCN1C1=C(Cl)C=C(C(F)(F)F)C=C1\C=C/1C(=O)NC(=O)S\1 FCICTBXGGPCMIE-SYUPGTOSSA-N 0.000 description 1
- JZCLSXXFXYSNOS-LFTLCWSBSA-N (5z)-5-[[2-[(3s)-3-aminopyrrolidin-1-yl]-3-ethoxyphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C([C@@H](N)CC1)N1C=1C(OCC)=CC=CC=1\C=C1/SC(=O)NC1=O JZCLSXXFXYSNOS-LFTLCWSBSA-N 0.000 description 1
- YALFZHPIDBMBTI-QENILXLESA-N (5z)-5-[[2-[(3s)-3-aminopyrrolidin-1-yl]-3-propan-2-yloxyphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C([C@@H](N)CC1)N1C=1C(OC(C)C)=CC=CC=1\C=C1/SC(=O)NC1=O YALFZHPIDBMBTI-QENILXLESA-N 0.000 description 1
- OINUTZGUCFIHAF-BZPKPHBRSA-N (5z)-5-[[2-[(3s)-3-aminopyrrolidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N)CCN1C1=CC=CC=C1\C=C/1C(=O)NC(=O)S\1 OINUTZGUCFIHAF-BZPKPHBRSA-N 0.000 description 1
- QFGNATOKKPXYOF-DKKOHOGUSA-N (5z)-5-[[2-[(3s,4s)-3-amino-4-hydroxypyrrolidin-1-yl]-3-chlorophenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](O)[C@@H](N)CN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 QFGNATOKKPXYOF-DKKOHOGUSA-N 0.000 description 1
- NJJGZBDOINCOFY-SSZFMOIBSA-N (5z)-5-[[3-(3-piperidin-1-ylpropoxy)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)\C1=C\C1=CC=CC(OCCCN2CCCCC2)=C1 NJJGZBDOINCOFY-SSZFMOIBSA-N 0.000 description 1
- SUPIJQUDABPQAC-UVTDQMKNSA-N (5z)-5-[[3-[(4-methylpiperazin-1-yl)methyl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CN(C)CCN1CC1=CC=CC(\C=C/2C(NC(=O)S\2)=O)=C1 SUPIJQUDABPQAC-UVTDQMKNSA-N 0.000 description 1
- SZQWWFBBLCIGLS-SSZFMOIBSA-N (5z)-5-[[3-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CN(C)CCN1CCCOC1=CC=CC(\C=C/2C(NC(=O)S\2)=O)=C1 SZQWWFBBLCIGLS-SSZFMOIBSA-N 0.000 description 1
- DMKSNYHOCJFURT-XFXZXTDPSA-N (5z)-5-[[3-chloro-2-(1,4-diazepan-1-yl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CCNCCN1C=1C(Cl)=CC=CC=1\C=C1/SC(=O)NC1=O DMKSNYHOCJFURT-XFXZXTDPSA-N 0.000 description 1
- YKWMZRDTFDCLPC-OJLMPMFISA-N (5z)-5-[[3-chloro-2-[(3r)-3-(2-hydroxyethylamino)piperidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](NCCO)CCCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 YKWMZRDTFDCLPC-OJLMPMFISA-N 0.000 description 1
- OBZOMRZVUQXCFA-OJLMPMFISA-N (5z)-5-[[3-chloro-2-[(3r)-3-(3,3,3-trifluoropropylamino)piperidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](NCCC(F)(F)F)CCCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 OBZOMRZVUQXCFA-OJLMPMFISA-N 0.000 description 1
- NNPXGWVESYSMDR-NWFCWYBLSA-N (5z)-5-[[3-chloro-2-[(3r)-3-(3-hydroxypropylamino)piperidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](NCCCO)CCCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 NNPXGWVESYSMDR-NWFCWYBLSA-N 0.000 description 1
- STVUNYMVAGCJLS-OKSBFYSISA-N (5z)-5-[[3-chloro-2-[(3r)-3-(dipropylamino)piperidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](N(CCC)CCC)CCCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 STVUNYMVAGCJLS-OKSBFYSISA-N 0.000 description 1
- ZEZRLGPUJDQXJR-NWFCWYBLSA-N (5z)-5-[[3-chloro-2-[(3r)-3-[2-(methylamino)ethylamino]piperidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](NCCNC)CCCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 ZEZRLGPUJDQXJR-NWFCWYBLSA-N 0.000 description 1
- OBDFOJUJSKEDRO-ZSOIEALJSA-N (5z)-5-[[3-chloro-2-[4-methyl-3-(methylamino)piperidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CC(C)C(NC)CN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 OBDFOJUJSKEDRO-ZSOIEALJSA-N 0.000 description 1
- MAXWYVPUCAYEHZ-ZSOIEALJSA-N (5z)-5-[[5-amino-2-[3-(dimethylamino)pyrrolidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1C(N(C)C)CCN1C1=CC=C(N)C=C1\C=C/1C(=O)NC(=O)S\1 MAXWYVPUCAYEHZ-ZSOIEALJSA-N 0.000 description 1
- MOMFXATYAINJML-UHFFFAOYSA-N 2-Acetylthiazole Chemical group CC(=O)C1=NC=CS1 MOMFXATYAINJML-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- XNMZHEQSIZCWTO-NUBYWOLOSA-N 4-[(3r)-3-aminopiperidin-1-yl]-3-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzoic acid Chemical compound C1[C@H](N)CCCN1C1=CC=C(C(O)=O)C=C1\C=C/1C(=O)NC(=O)S\1 XNMZHEQSIZCWTO-NUBYWOLOSA-N 0.000 description 1
- MVKANCZREUZKOU-OGGBREFQSA-N 4-[(3s)-3-aminopyrrolidin-1-yl]-3-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzoic acid Chemical compound C1[C@@H](N)CCN1C1=CC=C(C(O)=O)C=C1\C=C/1C(=O)NC(=O)S\1 MVKANCZREUZKOU-OGGBREFQSA-N 0.000 description 1
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 description 1
- FAKIMWQMJWWTMG-UHFFFAOYSA-N 5-[(2-amino-4,5-dimethoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1=C(OC)C(OC)=CC(N)=C1C=C1C(=O)NC(=O)S1 FAKIMWQMJWWTMG-UHFFFAOYSA-N 0.000 description 1
- ZWOZZWHFSDSLOU-UHFFFAOYSA-N 5-[(5-nitro-2-piperidin-1-ylphenyl)methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC([N+](=O)[O-])=CC=C1N1CCCCC1 ZWOZZWHFSDSLOU-UHFFFAOYSA-N 0.000 description 1
- GAHMOOOPIAAIJZ-UHFFFAOYSA-N 5-[[2-(3-aminopropoxy)-5-methoxyphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound COC1=CC=C(OCCCN)C(C=C2C(NC(=O)S2)=O)=C1 GAHMOOOPIAAIJZ-UHFFFAOYSA-N 0.000 description 1
- QIYASANSQHZITK-UHFFFAOYSA-N 5-[[2-(4-aminopiperidin-1-yl)-3-chloro-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CC(N)CCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 QIYASANSQHZITK-UHFFFAOYSA-N 0.000 description 1
- QMQYGDZSNITFMM-UHFFFAOYSA-N 5-[[2-(4-butyl-1,4-diazepan-1-yl)-3-chloro-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CN(CCCC)CCCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 QMQYGDZSNITFMM-UHFFFAOYSA-N 0.000 description 1
- ACBLHHDMVMZOHV-UHFFFAOYSA-N 5-[[2-(4-tert-butylpiperazin-1-yl)-3-chloro-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CN(C(C)(C)C)CCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 ACBLHHDMVMZOHV-UHFFFAOYSA-N 0.000 description 1
- UXHVFDZYEHJJKH-SNVBAGLBSA-N 5-[[2-[(3r)-3-aminopiperidin-1-yl]-3-chloro-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@H](N)CCCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 UXHVFDZYEHJJKH-SNVBAGLBSA-N 0.000 description 1
- XFFVJWMEBMHIMO-AOOOYVTPSA-N 5-[[2-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 XFFVJWMEBMHIMO-AOOOYVTPSA-N 0.000 description 1
- JXEQKRLOKRCMML-NSHDSACASA-N 5-[[2-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]-3-fluorophenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N(C)C)CCN1C1=C(F)C=CC=C1C=C1C(=O)NC(=O)S1 JXEQKRLOKRCMML-NSHDSACASA-N 0.000 description 1
- TYDHOLYQNCKTJR-ZDUSSCGKSA-N 5-[[2-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]-4-methylphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N(C)C)CCN1C1=CC(C)=CC=C1C=C1C(=O)NC(=O)S1 TYDHOLYQNCKTJR-ZDUSSCGKSA-N 0.000 description 1
- PMEOSYUJHIYVKZ-LBPRGKRZSA-N 5-[[2-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N(C)C)CCN1C1=CC=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 PMEOSYUJHIYVKZ-LBPRGKRZSA-N 0.000 description 1
- ZBFCRJCZTNEIOW-LBPRGKRZSA-N 5-[[2-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]-5-fluorophenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N(C)C)CCN1C1=CC=C(F)C=C1C=C1C(=O)NC(=O)S1 ZBFCRJCZTNEIOW-LBPRGKRZSA-N 0.000 description 1
- HGDRAPHCOZVBTC-LBPRGKRZSA-N 5-[[2-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]-5-methoxyphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC(OC)=CC=C1N1CC[C@H](N(C)C)C1 HGDRAPHCOZVBTC-LBPRGKRZSA-N 0.000 description 1
- XMUVMSZMRFGXIB-ZDUSSCGKSA-N 5-[[2-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]-5-methylphenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N(C)C)CCN1C1=CC=C(C)C=C1C=C1C(=O)NC(=O)S1 XMUVMSZMRFGXIB-ZDUSSCGKSA-N 0.000 description 1
- UXHVFDZYEHJJKH-JTQLQIEISA-N 5-[[2-[(3s)-3-aminopiperidin-1-yl]-3-chloro-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N)CCCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 UXHVFDZYEHJJKH-JTQLQIEISA-N 0.000 description 1
- NQXBUJUICQUFIT-UHFFFAOYSA-N 5-[[2-[3-(aminomethyl)piperidin-1-yl]-3-chloro-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1C(CN)CCCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 NQXBUJUICQUFIT-UHFFFAOYSA-N 0.000 description 1
- XKUPCQKNBPHFSG-UHFFFAOYSA-N 5-[[2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-3-chloro-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C=1C(C(F)(F)F)=CC(Cl)=C(N2CCN(CC=3C=C4OCOC4=CC=3)CC2)C=1C=C1SC(=O)NC1=O XKUPCQKNBPHFSG-UHFFFAOYSA-N 0.000 description 1
- UOQBYMVOOVBVNZ-JTQLQIEISA-N 5-[[2-chloro-6-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N(C)C)CCN1C1=CC=CC(Cl)=C1C=C1C(=O)NC(=O)S1 UOQBYMVOOVBVNZ-JTQLQIEISA-N 0.000 description 1
- PAANXPLSXFIGMW-NSHDSACASA-N 5-[[3-bromo-2-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N(C)C)CCN1C1=C(Br)C=CC=C1C=C1C(=O)NC(=O)S1 PAANXPLSXFIGMW-NSHDSACASA-N 0.000 description 1
- ZHPWHZMWMYLZQV-UHFFFAOYSA-N 5-[[3-chloro-2-(1,4-diazepan-1-yl)-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC(C(F)(F)F)=CC(Cl)=C1N1CCCNCC1 ZHPWHZMWMYLZQV-UHFFFAOYSA-N 0.000 description 1
- AJXNMNOJEYROEA-UHFFFAOYSA-N 5-[[3-chloro-2-(4-cyclopentylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC(C(F)(F)F)=CC(Cl)=C1N(CC1)CCN1C1CCCC1 AJXNMNOJEYROEA-UHFFFAOYSA-N 0.000 description 1
- SPIKHWFAEGMMHR-UHFFFAOYSA-N 5-[[3-chloro-2-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CN(C)CCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 SPIKHWFAEGMMHR-UHFFFAOYSA-N 0.000 description 1
- JYTYMNCPLFGMLM-UHFFFAOYSA-N 5-[[3-chloro-2-(4-morpholin-4-ylpiperidin-1-yl)-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC(C(F)(F)F)=CC(Cl)=C1N(CC1)CCC1N1CCOCC1 JYTYMNCPLFGMLM-UHFFFAOYSA-N 0.000 description 1
- RWDBZLUKAAUSHC-UHFFFAOYSA-N 5-[[3-chloro-2-(4-piperidin-1-ylpiperidin-1-yl)-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC(C(F)(F)F)=CC(Cl)=C1N(CC1)CCC1N1CCCCC1 RWDBZLUKAAUSHC-UHFFFAOYSA-N 0.000 description 1
- FTXLPRHUMRLOFM-UHFFFAOYSA-N 5-[[3-chloro-2-(4-propan-2-ylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CN(C(C)C)CCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 FTXLPRHUMRLOFM-UHFFFAOYSA-N 0.000 description 1
- SNMVUVIOJOQAHG-UHFFFAOYSA-N 5-[[3-chloro-2-(4-pyrrolidin-1-ylpiperidin-1-yl)-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC(C(F)(F)F)=CC(Cl)=C1N(CC1)CCC1N1CCCC1 SNMVUVIOJOQAHG-UHFFFAOYSA-N 0.000 description 1
- CSEZPMGYTAKIOJ-NSHDSACASA-N 5-[[3-chloro-2-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N(C)C)CCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 CSEZPMGYTAKIOJ-NSHDSACASA-N 0.000 description 1
- WCLDBXFEJREFNS-UHFFFAOYSA-N 5-[[3-chloro-2-[3-(3-methyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound CC1=NOC(C2CN(CCC2)C=2C(=CC(=CC=2Cl)C(F)(F)F)C=C2C(NC(=O)S2)=O)=N1 WCLDBXFEJREFNS-UHFFFAOYSA-N 0.000 description 1
- VMPTWAXWYYZFGU-UHFFFAOYSA-N 5-[[3-chloro-2-[3-(dimethylamino)propyl-methylamino]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound CN(C)CCCN(C)C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 VMPTWAXWYYZFGU-UHFFFAOYSA-N 0.000 description 1
- CZBMOCKXUDMRED-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CN(C)CCC1N1CCN(C=2C(=CC(=CC=2Cl)C(F)(F)F)C=C2C(NC(=O)S2)=O)CC1 CZBMOCKXUDMRED-UHFFFAOYSA-N 0.000 description 1
- RLUWZNJWIKLKCP-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CN(CCO)CCCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 RLUWZNJWIKLKCP-UHFFFAOYSA-N 0.000 description 1
- SDMSSSNUMQIPGL-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(2-hydroxyethyl)piperazin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CN(CCO)CCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 SDMSSSNUMQIPGL-UHFFFAOYSA-N 0.000 description 1
- RZBQYBODURYYCR-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(2-hydroxyethyl)piperidin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CC(CCO)CCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 RZBQYBODURYYCR-UHFFFAOYSA-N 0.000 description 1
- KGOAOQWVVJTDQT-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(2-methylpropyl)piperazin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CN(CC(C)C)CCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 KGOAOQWVVJTDQT-UHFFFAOYSA-N 0.000 description 1
- CYIADNCOTLOBMG-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC(C(F)(F)F)=CC(Cl)=C1N(CC1)CCN1CCN1CCOCC1 CYIADNCOTLOBMG-UHFFFAOYSA-N 0.000 description 1
- LEVWFFKJNVUTMF-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(3-hydroxypropyl)piperazin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CN(CCCO)CCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 LEVWFFKJNVUTMF-UHFFFAOYSA-N 0.000 description 1
- ZBBNKWGLUVVHOU-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(3-methyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound CC1=NOC(C2CCN(CC2)C=2C(=CC(=CC=2Cl)C(F)(F)F)C=C2C(NC(=O)S2)=O)=N1 ZBBNKWGLUVVHOU-UHFFFAOYSA-N 0.000 description 1
- FOAJUOHPNZLOCM-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(4-chloro-2-fluorophenyl)piperazin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound FC1=CC(Cl)=CC=C1N1CCN(C=2C(=CC(=CC=2Cl)C(F)(F)F)C=C2C(NC(=O)S2)=O)CC1 FOAJUOHPNZLOCM-UHFFFAOYSA-N 0.000 description 1
- QZNLFERGYQSRSW-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(4-fluorophenyl)piperazin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1=CC(F)=CC=C1N1CCN(C=2C(=CC(=CC=2Cl)C(F)(F)F)C=C2C(NC(=O)S2)=O)CC1 QZNLFERGYQSRSW-UHFFFAOYSA-N 0.000 description 1
- GHWDQWIMBBQROR-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(cyclopropylmethyl)piperazin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC(C(F)(F)F)=CC(Cl)=C1N(CC1)CCN1CC1CC1 GHWDQWIMBBQROR-UHFFFAOYSA-N 0.000 description 1
- XCVBSBVWFUJZJN-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(dimethylamino)piperidin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1CC(N(C)C)CCN1C1=C(Cl)C=C(C(F)(F)F)C=C1C=C1C(=O)NC(=O)S1 XCVBSBVWFUJZJN-UHFFFAOYSA-N 0.000 description 1
- SVKBAJHSSBBKLM-UHFFFAOYSA-N 5-[[3-chloro-2-[4-(pyridin-4-ylmethyl)piperazin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC(C(F)(F)F)=CC(Cl)=C1N(CC1)CCN1CC1=CC=NC=C1 SVKBAJHSSBBKLM-UHFFFAOYSA-N 0.000 description 1
- VCZKRRHUKGXBLG-UHFFFAOYSA-N 5-[[3-chloro-2-[4-[(2-chlorophenyl)methyl]piperazin-1-yl]-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC(C(F)(F)F)=CC(Cl)=C1N(CC1)CCN1CC1=CC=CC=C1Cl VCZKRRHUKGXBLG-UHFFFAOYSA-N 0.000 description 1
- OBQBTGCGTZKBCJ-UHFFFAOYSA-N 5-[[3-chloro-2-morpholin-4-yl-5-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC(C(F)(F)F)=CC(Cl)=C1N1CCOCC1 OBQBTGCGTZKBCJ-UHFFFAOYSA-N 0.000 description 1
- GQZNMLNYZBPJEJ-LBPRGKRZSA-N 5-[[5-bromo-2-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N(C)C)CCN1C1=CC=C(Br)C=C1C=C1C(=O)NC(=O)S1 GQZNMLNYZBPJEJ-LBPRGKRZSA-N 0.000 description 1
- ZLKXQCKKQVCPKO-LBPRGKRZSA-N 5-[[5-chloro-2-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound C1[C@@H](N(C)C)CCN1C1=CC=C(Cl)C=C1C=C1C(=O)NC(=O)S1 ZLKXQCKKQVCPKO-LBPRGKRZSA-N 0.000 description 1
- MZMOEKLRSIIVAX-UHFFFAOYSA-N 5-[[5-methoxy-2-[3-(propan-2-ylamino)propoxy]phenyl]methylidene]-1,3-thiazolidine-2,4-dione Chemical compound COC1=CC=C(OCCCNC(C)C)C(C=C2C(NC(=O)S2)=O)=C1 MZMOEKLRSIIVAX-UHFFFAOYSA-N 0.000 description 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 description 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- VWJNQFFHSJTVGQ-CJAAZZPWSA-N n-[(3s)-1-[2-chloro-6-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]pyrrolidin-3-yl]-1-methylimidazole-2-carboxamide Chemical compound CN1C=CN=C1C(=O)N[C@@H]1CN(C=2C(=CC=CC=2Cl)\C=C/2C(NC(=O)S\2)=O)CC1 VWJNQFFHSJTVGQ-CJAAZZPWSA-N 0.000 description 1
- KHRUUQWZCIYNKB-XKBFBRDOSA-N n-[(3s)-1-[2-chloro-6-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]pyrrolidin-3-yl]-1-methylpyrazole-4-carboxamide Chemical compound C1=NN(C)C=C1C(=O)N[C@@H]1CN(C=2C(=CC=CC=2Cl)\C=C/2C(NC(=O)S\2)=O)CC1 KHRUUQWZCIYNKB-XKBFBRDOSA-N 0.000 description 1
- ALFVXSXQXVFWAW-QENILXLESA-N n-[(3s)-1-[2-chloro-6-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]pyrrolidin-3-yl]-2-(dimethylamino)acetamide Chemical compound C1[C@@H](NC(=O)CN(C)C)CCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 ALFVXSXQXVFWAW-QENILXLESA-N 0.000 description 1
- ZIGBBKSLDXMKKW-LFTLCWSBSA-N n-[(3s)-1-[2-chloro-6-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]pyrrolidin-3-yl]-2-cyanoacetamide Chemical compound C([C@H](CC1)NC(=O)CC#N)N1C=1C(Cl)=CC=CC=1\C=C1/SC(=O)NC1=O ZIGBBKSLDXMKKW-LFTLCWSBSA-N 0.000 description 1
- NXKZGTGNGAQWGA-HKMIMPICSA-N n-[(3s)-1-[2-chloro-6-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]pyrrolidin-3-yl]-2-methoxyacetamide Chemical compound C1[C@@H](NC(=O)COC)CCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 NXKZGTGNGAQWGA-HKMIMPICSA-N 0.000 description 1
- FPNLPOQYPFTGCE-HAKPAVFJSA-N n-[(3s)-1-[2-chloro-6-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]pyrrolidin-3-yl]-2-pyridin-3-ylacetamide Chemical compound C([C@H](CC1)NC(=O)CC=2C=NC=CC=2)N1C=1C(Cl)=CC=CC=1\C=C1/SC(=O)NC1=O FPNLPOQYPFTGCE-HAKPAVFJSA-N 0.000 description 1
- DGFOYAGXKGPDEC-ZCQLHAAUSA-N n-[(3s)-1-[2-chloro-6-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]pyrrolidin-3-yl]-2-pyridin-4-ylacetamide Chemical compound C([C@H](CC1)NC(=O)CC=2C=CN=CC=2)N1C=1C(Cl)=CC=CC=1\C=C1/SC(=O)NC1=O DGFOYAGXKGPDEC-ZCQLHAAUSA-N 0.000 description 1
- ACYSHADFNCYUSL-CJAAZZPWSA-N n-[(3s)-1-[2-chloro-6-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]pyrrolidin-3-yl]-4-sulfamoylbutanamide Chemical compound C1[C@@H](NC(=O)CCCS(=O)(=O)N)CCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 ACYSHADFNCYUSL-CJAAZZPWSA-N 0.000 description 1
- TZLCLYRLBKRXCX-OJNRTJSBSA-N n-[(3s)-1-[2-chloro-6-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]pyrrolidin-3-yl]-n',n'-dimethylbutanediamide Chemical compound C1[C@@H](NC(=O)CCC(=O)N(C)C)CCN1C1=C(Cl)C=CC=C1\C=C/1C(=O)NC(=O)S\1 TZLCLYRLBKRXCX-OJNRTJSBSA-N 0.000 description 1
- JIDWIAWAFBHNSW-RGEXLXHISA-N n-[2-(dimethylamino)ethyl]-4-[2-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]-n-methylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N(C)CCN(C)C)=CC=C1C1=CC=CC=C1\C=C/1C(=O)NC(=O)S\1 JIDWIAWAFBHNSW-RGEXLXHISA-N 0.000 description 1
- WAHVGCWMFGAKGI-SXGWCWSVSA-N n-[4-[3-(dimethylamino)pyrrolidin-1-yl]-3-[(z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]acetamide Chemical compound C1C(N(C)C)CCN1C1=CC=C(NC(C)=O)C=C1\C=C/1C(=O)NC(=O)S\1 WAHVGCWMFGAKGI-SXGWCWSVSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 125000003396 thiol group Chemical class [H]S* 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7763908P | 2008-07-02 | 2008-07-02 | |
| US61/077,639 | 2008-07-02 | ||
| US18327809P | 2009-06-02 | 2009-06-02 | |
| US61/183,278 | 2009-06-02 | ||
| PCT/GB2009/050773 WO2010001169A2 (en) | 2008-07-02 | 2009-07-02 | Chemical compounds 251 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013031176A Division JP2013139459A (ja) | 2008-07-02 | 2013-02-20 | 化学化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011526616A JP2011526616A (ja) | 2011-10-13 |
| JP2011526616A5 true JP2011526616A5 (https=) | 2013-04-11 |
| JP5261575B2 JP5261575B2 (ja) | 2013-08-14 |
Family
ID=41050276
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011515631A Expired - Fee Related JP5261575B2 (ja) | 2008-07-02 | 2009-07-02 | 化学化合物 |
| JP2013031176A Ceased JP2013139459A (ja) | 2008-07-02 | 2013-02-20 | 化学化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013031176A Ceased JP2013139459A (ja) | 2008-07-02 | 2013-02-20 | 化学化合物 |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US8901307B2 (https=) |
| EP (1) | EP2310010A2 (https=) |
| JP (2) | JP5261575B2 (https=) |
| KR (1) | KR20110031367A (https=) |
| CN (2) | CN102137666B (https=) |
| AR (1) | AR072791A1 (https=) |
| AU (1) | AU2009265362B2 (https=) |
| BR (1) | BRPI0914599A2 (https=) |
| CA (1) | CA2729557A1 (https=) |
| CL (1) | CL2010001636A1 (https=) |
| CO (1) | CO6341555A2 (https=) |
| CR (1) | CR20110016A (https=) |
| DO (1) | DOP2010000408A (https=) |
| EA (1) | EA018989B1 (https=) |
| EC (1) | ECSP10010735A (https=) |
| HN (1) | HN2010002786A (https=) |
| IL (1) | IL210127A0 (https=) |
| MX (1) | MX2010014233A (https=) |
| MY (1) | MY155961A (https=) |
| NI (1) | NI201100007A (https=) |
| NZ (1) | NZ590859A (https=) |
| PE (1) | PE20120304A1 (https=) |
| SV (1) | SV2011003786A (https=) |
| TW (1) | TWI461423B (https=) |
| UY (1) | UY31952A (https=) |
| WO (1) | WO2010001169A2 (https=) |
| ZA (1) | ZA201100844B (https=) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202003901UA (en) | 2005-12-13 | 2020-05-28 | Incyte Holdings Corp | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| KR20150036210A (ko) | 2007-06-13 | 2015-04-07 | 인사이트 코포레이션 | 야누스 키나제 억제제（Ｒ）―３―（４―（７Ｈ―피롤로［２，３－ｄ］피리미딘―4―일）―1Ｈ―피라졸―1―일）―３―사이클로펜틸프로판니트릴의 염 |
| UY31952A (es) * | 2008-07-02 | 2010-01-29 | Astrazeneca Ab | 5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim |
| AR076794A1 (es) | 2009-05-22 | 2011-07-06 | Incyte Corp | Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo [2,3-d]pirimidinas y pirrol-3-il-pirrolo [2,3-d ]pirimidinas como inhibidores de la quinasa janus y composiciones farmaceuticas que los contienen |
| SI2432472T1 (sl) | 2009-05-22 | 2019-11-29 | Incyte Holdings Corp | 3-(4-(7H-pirolo(2,3-d)pirimidin-4-il)-1H-pirazol-1-il)oktan- ali heptan-nitril kot inhibitorji JAK |
| TW201113285A (en) | 2009-09-01 | 2011-04-16 | Incyte Corp | Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
| EP3354652B1 (en) | 2010-03-10 | 2020-05-06 | Incyte Holdings Corporation | Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| PE20130216A1 (es) | 2010-05-21 | 2013-02-27 | Incyte Corp | Formulacion topica para un inhibidor de jak |
| US9034884B2 (en) | 2010-11-19 | 2015-05-19 | Incyte Corporation | Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors |
| PE20140146A1 (es) | 2010-11-19 | 2014-02-06 | Incyte Corp | Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak |
| CN103797010B (zh) | 2011-06-20 | 2016-02-24 | 因塞特控股公司 | 作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物 |
| TW201313721A (zh) | 2011-08-18 | 2013-04-01 | Incyte Corp | 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物 |
| UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
| WO2013051672A1 (ja) * | 2011-10-04 | 2013-04-11 | 株式会社ヤクルト本社 | チアゾリジン誘導体又はその塩を有効成分とする医薬品 |
| MY158040A (en) * | 2012-03-30 | 2016-08-30 | Rohto Pharma | Novel benzylidene azolidine derivative or salt thereof |
| TW201406761A (zh) | 2012-05-18 | 2014-02-16 | Incyte Corp | 做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物 |
| JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
| WO2014007228A1 (ja) | 2012-07-03 | 2014-01-09 | 小野薬品工業株式会社 | ソマトスタチン受容体作動活性を有する化合物およびその医薬用途 |
| PH12020551186B1 (en) | 2012-11-15 | 2024-03-20 | Incyte Holdings Corp | Sustained-release dosage forms of ruxolitinib |
| ES2649156T3 (es) | 2013-01-14 | 2018-01-10 | Incyte Holdings Corporation | Compuestos bicíclicos de carboxamida aromática útiles como inhibidores de quinasas Pim |
| PE20191245A1 (es) | 2013-01-15 | 2019-09-18 | Incyte Holdings Corp | Compuestos de tiazolcarboxamidas y piridinacarboxamida utiles como inhibidores de quinasa pim |
| RS62867B1 (sr) | 2013-03-06 | 2022-02-28 | Incyte Holdings Corp | Postupci i intermedijeri za dobijanje inhibitora jak |
| JP6378918B2 (ja) * | 2013-04-03 | 2018-08-22 | 株式会社ヤクルト本社 | チアゾリジン誘導体又はその塩を有効成分とするＰｉｍ阻害剤 |
| US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
| US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
| SMT202000315T1 (it) | 2013-08-07 | 2020-07-08 | Incyte Corp | Forme di dosaggio a rilascio prolungato per un inibitore di jak1 |
| EA201690458A1 (ru) | 2013-08-23 | 2016-07-29 | Инсайт Корпорейшн | Фуро- и тиенопиридинкарбоксамиды, используемые в качестве ингибиторов pim-киназы |
| TW201601769A (zh) * | 2013-09-27 | 2016-01-16 | 樂敦製藥股份有限公司 | 皮膚外用組成物 |
| WO2015046390A1 (ja) * | 2013-09-27 | 2015-04-02 | ロート製薬株式会社 | 新規ベンジリデンアゾリジン誘導体またはその塩を含む皮膚外用組成物 |
| US20170145005A1 (en) * | 2014-02-13 | 2017-05-25 | The University Of Tokyo | Kinase inhibitor |
| US9498467B2 (en) | 2014-05-30 | 2016-11-22 | Incyte Corporation | Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1 |
| JP5857104B2 (ja) * | 2014-06-17 | 2016-02-10 | ロート製薬株式会社 | ベンジリデンアゾリジン誘導体またはその塩を含む皮膚外用組成物 |
| US9822124B2 (en) | 2014-07-14 | 2017-11-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors |
| US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
| US10195189B2 (en) | 2014-12-15 | 2019-02-05 | Prosetta Antiviral, Inc. | 2-phenethenyltetrahydro isoquinolines useful as anti-HIV compounds |
| CN105985298B (zh) * | 2015-02-10 | 2018-02-23 | 湖南大学 | 2‑[(5‑卤噻唑‑2‑基)亚氨基]‑5‑亚苄基噻唑啉酮及其制备方法与应用 |
| AU2016229294B2 (en) | 2015-03-06 | 2021-11-04 | Beyondspring Pharmaceuticals, Inc. | Method of treating cancer associated with a RAS mutation |
| CN106032365B (zh) * | 2015-03-11 | 2018-03-23 | 湖南大学 | 2‑(噻唑‑2‑基)亚氨基‑5‑亚苄基噻唑啉酮及其制备方法与应用 |
| WO2016196244A1 (en) | 2015-05-29 | 2016-12-08 | Incyte Corporation | Pyridineamine compounds useful as pim kinase inhibitors |
| JP6969848B2 (ja) | 2015-07-13 | 2021-11-24 | ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド | プリナブリン組成物 |
| TWI734699B (zh) | 2015-09-09 | 2021-08-01 | 美商英塞特公司 | Ｐｉｍ激酶抑制劑之鹽 |
| US9920032B2 (en) | 2015-10-02 | 2018-03-20 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
| KR20180105685A (ko) | 2016-02-08 | 2018-09-28 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 투카레솔 또는 이의 유사체를 함유하는 조성물 |
| WO2017176812A1 (en) | 2016-04-05 | 2017-10-12 | Immune Sensor, Llc | cGAS ANTAGONIST COMPOUNDS |
| JP7025416B2 (ja) | 2016-06-06 | 2022-02-24 | ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド | 好中球減少症を低減させるための組成物および方法 |
| WO2017216726A1 (en) | 2016-06-13 | 2017-12-21 | Glaxosmithkline Intellectual Property Development Limited | Substituted pyridines as inhibitors of dnmt1 |
| WO2018129381A1 (en) | 2017-01-06 | 2018-07-12 | Beyondspring Pharmaceuticals, Inc. | Tubulin binding compounds and therapeutic use thereof |
| BR112019015974A2 (pt) | 2017-02-01 | 2020-03-31 | Beyondspring Pharmaceuticals, Inc. | Método para reduzir neutropenia |
| CA3067746A1 (en) * | 2017-06-30 | 2019-01-03 | The Regents Of The University Of California | Compositions and methods for modulating hair growth |
| EP3706735A1 (en) | 2017-11-06 | 2020-09-16 | Snap Bio, Inc. | Pim kinase inhibitor compositions, methods, and uses thereof |
| WO2019113487A1 (en) | 2017-12-08 | 2019-06-13 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
| KR20200112881A (ko) | 2018-01-24 | 2020-10-05 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법 |
| SG11202007164UA (en) | 2018-01-30 | 2020-08-28 | Incyte Corp | Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one) |
| SMT202400306T1 (it) | 2018-03-30 | 2024-09-16 | Incyte Corp | Trattamento dell'idrosadenite suppurativa utilizzando inibitori di jak. |
| JP7491510B2 (ja) * | 2018-04-26 | 2024-05-28 | メディシナル バイオコンバージェンス リサーチ センター | ｍＴＯＲ阻害剤としての新規化合物及びその用途 |
| CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
| WO2022006040A1 (en) | 2020-06-30 | 2022-01-06 | The Regents Of The University Of California | Compositions and methods for modulating hair growth |
| WO2022086920A1 (en) * | 2020-10-20 | 2022-04-28 | Blacksmith Medicines, Inc. | Glutaminyl-peptide cyclotransferase like (qpctl) protein inhibitors and uses thereof |
| CA3215047A1 (en) | 2021-04-09 | 2022-10-13 | Lan Huang | Therapeutic compositions and methods for treating tumors |
| WO2023039170A1 (en) * | 2021-09-09 | 2023-03-16 | Musc Foundation For Research Development | Selective targeting of cd38 activity as an immunostimulatory and antitumor strategy |
| CN116354901B (zh) * | 2023-04-12 | 2024-04-26 | 郑州大学 | 一种噻唑烷二酮类化合物及其制备方法和应用 |
| WO2025017207A1 (en) | 2023-07-20 | 2025-01-23 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Inhibitors of smndc1 and their therapeutic use |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE62214B1 (en) * | 1988-05-25 | 1995-01-11 | Warner Lambert Co | Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents |
| CZ289317B6 (cs) | 1994-04-11 | 2002-01-16 | Sankyo Company Limited | Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití |
| JP3668291B2 (ja) | 1995-06-16 | 2005-07-06 | 久光製薬株式会社 | 新規なピペリジン誘導体 |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| DE69720965T2 (de) | 1996-02-13 | 2004-02-05 | Astrazeneca Ab | Chinazolinderivate und deren verwendung als vegf hemmer |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| UA56185C2 (uk) | 1996-09-30 | 2003-05-15 | Пфайзер Інк. | Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування |
| TW577875B (en) * | 1997-01-31 | 2004-03-01 | Shionogi & Co | Pyrrolidine derivatives with inhibitory activity for phospholipase A2 |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| KR20010099634A (ko) * | 1999-07-01 | 2001-11-09 | 할리 켈빈 비. | 텔로머라제 저해제 및 그 사용 방법 |
| CN1155586C (zh) | 1999-08-23 | 2004-06-30 | 杏林制药株式会社 | 取代的苄基噻唑烷-2,4-二酮衍生物 |
| TW593293B (en) * | 1999-08-23 | 2004-06-21 | Kyorin Seiyaku Kk | Substituted benzylthiazolidine-2,4-dione derivatives |
| WO2001034133A2 (en) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| AU2001258628A1 (en) | 2000-05-31 | 2001-12-11 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| MXPA02012905A (es) | 2000-07-07 | 2004-07-30 | Angiogene Pharm Ltd | Derivados de colquinol como agentes de dano vascular.. |
| MXPA02012903A (es) | 2000-07-07 | 2004-07-30 | Angiogene Pharm Ltd | Derivados de colquinol como inhibidores de angiogenesis. |
| US6452014B1 (en) * | 2000-12-22 | 2002-09-17 | Geron Corporation | Telomerase inhibitors and methods of their use |
| JP4782564B2 (ja) | 2002-07-10 | 2011-09-28 | メルク セローノ ソシエテ アノニム | アゾリジノン−ビニル縮合−ベンゼン誘導体 |
| US20050038098A1 (en) | 2003-04-18 | 2005-02-17 | Catherine Tachdjian | Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseases |
| WO2005105780A2 (en) | 2004-04-28 | 2005-11-10 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of rock and other protein kinases |
| WO2006069186A2 (en) | 2004-12-22 | 2006-06-29 | The Ohio State Research Foundation | Small molecule bcl-xl/bcl-2 binding inhibitors |
| EP2217235A4 (en) * | 2007-11-15 | 2011-01-12 | Musc Found For Res Dev | INHIBITORS OF PIM PROTEIN KINASES, COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER |
| UY31952A (es) * | 2008-07-02 | 2010-01-29 | Astrazeneca Ab | 5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim |
-
2009
- 2009-07-01 UY UY0001031952A patent/UY31952A/es not_active Application Discontinuation
- 2009-07-01 TW TW098122261A patent/TWI461423B/zh not_active IP Right Cessation
- 2009-07-02 MX MX2010014233A patent/MX2010014233A/es active IP Right Grant
- 2009-07-02 AR ARP090102486A patent/AR072791A1/es unknown
- 2009-07-02 CN CN200980134849.5A patent/CN102137666B/zh not_active Expired - Fee Related
- 2009-07-02 US US13/000,138 patent/US8901307B2/en not_active Expired - Fee Related
- 2009-07-02 BR BRPI0914599A patent/BRPI0914599A2/pt not_active IP Right Cessation
- 2009-07-02 CN CN201410037508.9A patent/CN103804371A/zh active Pending
- 2009-07-02 WO PCT/GB2009/050773 patent/WO2010001169A2/en not_active Ceased
- 2009-07-02 EA EA201100119A patent/EA018989B1/ru not_active IP Right Cessation
- 2009-07-02 CA CA2729557A patent/CA2729557A1/en not_active Abandoned
- 2009-07-02 AU AU2009265362A patent/AU2009265362B2/en not_active Ceased
- 2009-07-02 KR KR1020117002754A patent/KR20110031367A/ko not_active Ceased
- 2009-07-02 JP JP2011515631A patent/JP5261575B2/ja not_active Expired - Fee Related
- 2009-07-02 NZ NZ590859A patent/NZ590859A/xx not_active IP Right Cessation
- 2009-07-02 MY MYPI2010006322A patent/MY155961A/en unknown
- 2009-07-02 PE PE2010001221A patent/PE20120304A1/es not_active Application Discontinuation
- 2009-07-02 EP EP09772849A patent/EP2310010A2/en not_active Withdrawn
-
2010
- 2010-12-20 IL IL210127A patent/IL210127A0/en unknown
- 2010-12-30 HN HN2010002786A patent/HN2010002786A/es unknown
- 2010-12-30 EC EC2010010735A patent/ECSP10010735A/es unknown
- 2010-12-30 CL CL2010001636A patent/CL2010001636A1/es unknown
- 2010-12-30 DO DO2010000408A patent/DOP2010000408A/es unknown
-
2011
- 2011-01-03 SV SV2011003786A patent/SV2011003786A/es unknown
- 2011-01-05 NI NI201100007A patent/NI201100007A/es unknown
- 2011-01-10 CR CR20110016A patent/CR20110016A/es unknown
- 2011-02-01 ZA ZA2011/00844A patent/ZA201100844B/en unknown
- 2011-02-01 CO CO11011427A patent/CO6341555A2/es active IP Right Grant
-
2013
- 2013-02-20 JP JP2013031176A patent/JP2013139459A/ja not_active Ceased
-
2014
- 2014-07-24 US US14/339,981 patent/US20150051185A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011526616A5 (https=) | ||
| JP5261575B2 (ja) | 化学化合物 | |
| JP2017530999A5 (https=) | ||
| JP2010513444A5 (https=) | ||
| JP2014511869A5 (https=) | ||
| CA2877589C (en) | Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders | |
| JP2007508346A5 (https=) | ||
| JP2010533158A5 (https=) | ||
| JP2018048190A (ja) | ヒトプロテインチロシンホスファターゼ阻害剤および使用法 | |
| JP2005526814A5 (https=) | ||
| JP2018511587A5 (https=) | ||
| JP2006507302A5 (https=) | ||
| JP2005526723A5 (https=) | ||
| JP2007528887A5 (https=) | ||
| JP2007534687A5 (https=) | ||
| RU2009101911A (ru) | Производные пиридина и пиразина в качестве ингибиторов mnk-киназы | |
| JP2007504160A5 (https=) | ||
| JP2012520867A5 (https=) | ||
| JP2011504497A5 (https=) | ||
| JP2007520540A5 (https=) | ||
| JP2003512353A5 (https=) | ||
| JP2013512900A5 (https=) | ||
| RU2013143028A (ru) | Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ | |
| JP2014523400A5 (https=) | ||
| RS54718B1 (sr) | Derivati 1,2,4-tiazolidin-3-ona i njihova upotreba u lečenju kancera |